Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14279/13696
Title: | Galactorrhea, mastodynia and gynecomastia as the first manifestation of lung adenocarcinoma. A case report | Authors: | Lazopoulos, Achileas Krimiotis, Dimitris Schizas, Nikolaos V. Rallis, Thomas Gogakos, A.S. Chatzinikolaou, Fotis Tsiouda, Theodora Zarogoulidis, Paul Sarafis, Pavlos Kamparoudi, Parthena Paliouras, Dimitrios V. Barbetakis, Nikolaos G. |
Major Field of Science: | Medical and Health Sciences | Field Category: | Clinical Medicine | Keywords: | Galactorrhea;Gynecomastia;Lung adenocarcinoma;Mastodynia | Issue Date: | 2019 | Source: | Respiratory Medicine Case Reports, 2019, vol. 26, pp. 146-149 | Volume: | 26 | Start page: | 146 | End page: | 149 | Journal: | Respiratory Medicine Case Reports | Abstract: | Gynecomastia with mastodynia and galactorrhea as a paraneoplastic syndrome due to lung cancer with complete response after surgical excision is rare. A 62-year-old Caucasian male presented with mastodynia, galactorrhea and right breast enlargement. Chest x-ray revealed a left upper lobe tumor. The patient had high levels of serum beta-human chorionic gonadotropin (b-HCG) and prolactine. Complete staging was negative for metastases. A typical left upper lobectomy with radical mediastinal lymph node dissection was performed. Pathology report was consistent with a poorly differentiated adenocarcinoma (T2N1M0). Immunohistochemically, multinucleate cells and occasional mononucleate tumor cells showed positivity for human chorionic gonadotropin. The patient received adjuvant chemotherapy with cisplatin - navelbine. One year later physical examination showed regression of both gynecomastia and mastodynia and there was no nipple discharge, while he is free from local or distant metastatic disease and the b-HCG level is normal (1,59 mIU/ml). This case represents a very rare, first manifestation of lung cancer. Galactorrhea, mastodynia and gynecomastia were the initial symptoms, which totally resolved following the successful surgical resection and adjuvant chemotherapy. In this case, prolactin and b-HCG are useful biomarkers during follow up for checking local or distal recurrence of the disease. | ISSN: | 22130071 | DOI: | 10.1016/j.rmcr.2018.12.001 | Rights: | © Elsevier | Type: | Article | Affiliation : | Theagenion Anticancer Hospital Aristotle University of Thessaloniki Saint Luke Private Hospital Cyprus University of Technology |
Publication Type: | Peer Reviewed |
Appears in Collections: | Άρθρα/Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
1-s2.0-S2213007118302272-main.pdf | Fulltext | 1.17 MB | Adobe PDF | View/Open |
CORE Recommender
SCOPUSTM
Citations
4
checked on Nov 6, 2023
WEB OF SCIENCETM
Citations
4
Last Week
0
0
Last month
0
0
checked on Oct 29, 2023
Page view(s) 50
350
Last Week
0
0
Last month
2
2
checked on Dec 3, 2024
Download(s)
109
checked on Dec 3, 2024
Google ScholarTM
Check
Altmetric
Items in KTISIS are protected by copyright, with all rights reserved, unless otherwise indicated.